A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer

Conventional preoperative chemotherapy regimens have only limited efficacy in hormone receptor positive (HR+) breast cancer and new approaches are needed. We hypothesized that capecitabine, which is effective in metastatic breast cancer, may be an active preoperative treatment for HR+ breast cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Tolaney, Sara M, Jeong, Joon, Guo, Hao, Brock, Jane, Morganstern, Daniel, Come, Steven E, Golshan, Mehra, Bellon, Jennifer, Winer, Eric P, Krop, Ian E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987079/
https://www.ncbi.nlm.nih.gov/pubmed/24464780
http://dx.doi.org/10.1002/cam4.164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987079/
https://www.ncbi.nlm.nih.gov/pubmed/24464780
http://dx.doi.org/10.1002/cam4.164

Ejemplares similares